Hi-Tech Pharmacal Co. (HITK) Enters Overbought Territory - Tale of the Tape

By
A A A

Hi-Tech Pharmacal Co. ( HITK ) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because HITK is now in overbought territory with an RSI value of 79.83 Furthermore, estimates for the Hi-Tech Pharmacal Co have been coming down, pushing it to a Zacks Rank #5 (Strong Sell). This suggests that investors may better off exiting this stock before it falls back to Earth.



HI TECH PHARMA (HITK): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Investing Ideas , Stocks

Referenced Stocks: HITK

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Tiny Homes With Big Appeal
Tiny Homes With Big Appeal          

Stocks

Referenced

Most Active by Volume

270,887,127
    $93.89 unch
225,243,115
  • $40.93 ▼ 2.74%
135,900,109
  • $47.52 ▲ 1.80%
89,467,924
  • $5.35 ▼ 1.11%
85,105,358
  • $16.95 ▼ 0.53%
80,748,539
  • $39.80 ▼ 4.21%
68,491,586
  • $3.57 ▼ 1.79%
62,097,356
  • $100.96 ▼ 0.82%
As of 9/19/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com